RxDoctor Payments Data

Candice Bolling

Physician Assistant · Saint Paul, VANPI 1477736684

Payments from drug & device makers

$2,220in general payments, 2019–2025

Across 131 payments — averaging $16.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$406
  • Johnson & Johnson$226
  • GSK$206
  • AbbVie$206
  • AstraZeneca$176
  • Abbott$169
  • plus $830 from 14 others

What the payments were for

  • Food & beverage$2,220100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,220 in reported general payments places this provider in the 80th percentile of 3,376 physician assistant providers in Virginia.

See all physician assistant providers in Virginia

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide154$196,877
OzempicSemaglutide159$188,368
Trelegy ElliptaFluticasone/Umeclidin/Vilanter177$135,894
EliquisApixaban119$111,369
JardianceEmpagliflozin107$94,324
FarxigaDapagliflozin Propanediol74$57,299
TrulicityDulaglutide35$39,864
TrintellixVortioxetine Hydrobromide49$39,074
LinzessLinaclotide40$33,990
XareltoRivaroxaban45$33,450
Tresiba Flextouch U-200Insulin Degludec30$33,318
Breztri AerosphereBudesonide/Glycopyr/Formoterol52$31,182
RybelsusSemaglutide20$27,269
JanuviaSitagliptin Phosphate27$19,711
NucyntaTapentadol Hcl20$15,685

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$39$236,741189 claims
Novo NordiskOzempic, Rybelsus$406$215,637179 claims
GSKTrelegy Ellipta, Breo Ellipta$206$140,899189 claims
Boehringer IngelheimJardiance, Spiriva Respimat, Stiolto Respimat$40$121,819143 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$176$100,455177 claims
Takeda Pharmaceuticals U.S.A., Inc.Trintellix$18$39,07449 claims
AbbVieLinzess$206$33,99040 claims
Johnson & JohnsonXarelto$226$33,45045 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,376 physician assistant providers in Virginia.

Other physician assistant in Saint Paul

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →